P068 Sequencing to identify potential targets of resistance to primary therapy
Crystal Williams, B Leyland-Jones(Amgen (United States)), Amy Krie(Amgen (United States)), Brad Solomon, Brandon Young(Avera Health), K. Williams, J. Klein, P. De(Avera Health), Scooter Willis(Avera Health), Neelendu Dey(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa)
Cited by 0
Related Papers
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k
Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study
|Nature Medicine|2019|726
Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-naïve study
|Genome Medicine|2021|91